{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470630345
| IUPAC_name = 5-ethyl-5-[(1''E'')-1-methylbut-1-en-1-yl]pyrimidine-2,4,6(1''H'',3''H'',5''H'')-trione
| image = Vinbarbital.png
| width = 100

<!--Clinical data-->
| tradename =  
| pregnancy_category = 
| legal_CA = Schedule IV
| legal_US = Schedule III
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 2430-49-1
| ATC_prefix = N05
| ATC_suffix = CA09
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 503565
| PubChem = 5284636
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4447681
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7NZH2C1T6O
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07321

<!--Chemical data-->
| C=11 | H=16 | N=2 | O=3 
| molecular_weight = 224.256 g/mol
| smiles = O=C1NC(=O)NC(=O)C1(/C(=C/CC)C)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h6H,4-5H2,1-3H3,(H2,12,13,14,15,16)/b7-6+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RAFOHKSPUDGZPR-VOTSOKGWSA-N
}}
'''Vinbarbital''' is a hypnotic drug which is a [[barbiturate]] derivative.<ref>{{Cite journal 
| last1 = Mueller | first1 = V. A. 
| title = An analysis and evaluation of vinbarbital sodium for obstetric amnesia and analgesia 
| journal = American Journal of Obstetrics and Gynecology 
| volume = 59 
| issue = 3 
| pages = 679â€“684 
| year = 1950 
| pmid = 15405833
 | doi=10.1016/0002-9378(50)90253-5
}}</ref> It was developed by Sharp and Dohme in 1939.<ref>{{Patent |US|2187703}}</ref>

==References==
{{Reflist}}

{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:Sedatives]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}